What is the recommended dosing schedule for the Rabipur (rabies vaccine) injection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Rabipur (Rabies Vaccine) Injection Dosing Schedule

For post-exposure prophylaxis in previously unvaccinated individuals, Rabipur should be administered as a 4-dose regimen with 1.0 mL intramuscular injections on days 0,3,7, and 14. 1

Post-Exposure Prophylaxis (PEP) Dosing

Previously Unvaccinated Individuals

  • Vaccine dosing: 1.0 mL of Rabipur administered intramuscularly on days 0,3,7, and 14 1, 2
  • Injection site: Deltoid area for adults and older children; anterolateral thigh for younger children 1
  • Important: Never administer in the gluteal area as this may result in lower neutralizing antibody titers 1
  • Rabies Immunoglobulin (RIG): 20 IU/kg body weight administered on day 0 2
    • Infiltrate full dose around and into wounds if anatomically feasible
    • Administer any remaining volume intramuscularly at a site distant from vaccine administration
    • Never administer RIG in the same syringe or at the same anatomic site as the vaccine

Previously Vaccinated Individuals

  • Vaccine dosing: 1.0 mL of Rabipur administered intramuscularly on days 0 and 3 only 1
  • Injection site: Same as for unvaccinated individuals (deltoid area)
  • Note: RIG should NOT be administered to previously vaccinated persons 1

Special Populations

  • Immunocompromised patients: Should receive a 5-dose vaccination regimen on days 0,3,7,14, and 28, plus RIG 1, 2
  • Children: Receive the same vaccine volume (1.0 mL) as adults 1

Pre-Exposure Prophylaxis Dosing

  • Standard regimen: 1.0 mL of Rabipur administered intramuscularly on days 0,7, and 21 or 28 2, 3
  • Booster doses: Based on risk category and antibody titers 3
    • Continuous risk: Check antibody titers every 6 months
    • Frequent risk: Check antibody titers every 2 years
    • Infrequent risk: No routine boosters required

Important Clinical Considerations

Wound Care

  • All post-exposure prophylaxis should begin with immediate thorough cleansing of all wounds with soap and water for at least 15 minutes 2
  • If available, a virucidal agent such as povidone-iodine solution should be used to irrigate the wounds 1

Common Pitfalls to Avoid

  1. Incorrect injection site: Never administer in the gluteal area as this reduces immunogenicity 1
  2. Delayed initiation: PEP should begin as soon as possible after exposure, ideally within 24 hours 2
  3. Improper RIG administration: Failure to infiltrate wounds properly with RIG can reduce effectiveness 2
  4. Mixing RIG and vaccine: Never administer RIG in the same syringe as the vaccine 1
  5. Exceeding recommended RIG dose: This may suppress active antibody production 1

Effectiveness

The 4-dose vaccine regimen replaced the previous 5-dose regimen in 2010 based on evidence that it provides adequate protection while reducing costs and the burden of additional medical visits 2. When administered correctly, post-exposure prophylaxis is nearly 100% effective in preventing rabies 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Rabies Post-Exposure Prophylaxis Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.